# A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia

> **NCT00424372** · PHASE3 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 126 (actual)

## Conditions studied

- Neuralgia, Postherpetic

## Interventions

- **DRUG:** pregabalin

## Key facts

- **NCT ID:** NCT00424372
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01-12
- **Primary completion:** 2008-08-19
- **Final completion:** 2008-08-19
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2021-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00424372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00424372, "A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00424372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*